Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study

被引:12
|
作者
Song, M. [1 ]
Ware, R. [2 ]
Doan, T. N. [3 ]
Harley, D. [1 ]
机构
[1] Mater Res Inst Univ Queensland MRI UQ, Queensland Ctr Intellectual & Dev Disabil QCIDD, Room 233,Aubigny Pl,Raymond Terrace, South Brisbane, Qld 4101, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia
[3] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia
关键词
antipsychotics; challenging behaviour; cohort study; intellectual disability; problem behaviour; psychotropics;
D O I
10.1111/jir.12685
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background Longitudinal data on medication use in adults with intellectual disability (ID) are scarce. We describe the longitudinal use of and factors associated with psychotropic medication prescribing in adults with ID living in the Australian community. Methods Longitudinal data were obtained from adults with ID in the community in Queensland, Australia, between 1999 and 2015. Participant characteristics and medication use information were extracted from baseline questionnaires and health check booklets. Logistic regression was used to investigate the associations between participant characteristics and psychotropic medication use, commencement or cessation. Results Longitudinal data were available for 138 participants on 697 reviews. The proportion of participants prescribed psychotropic medications increased from 43% to 54% between 1999 and 2015. The rates of commencement and cessation of psychotropic medications between consecutive time periods ranged from 9% to 18% and 7% to 15%, respectively. Challenging behaviour was associated with psychotropic medication use (adjusted odds ratio = 4.1; 95% confidence interval: 2.1-7.9). Presence of challenging behaviour, either consistent or newly identified, was positively associated with ongoing use or commencement of psychotropic medications. Conclusions Psychotropic medications are commonly prescribed to adults with ID. Challenging behaviour is positively associated with ongoing use and commencement.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [31] Psychotropic medication use and intimate partner violence at 4 years postpartum: Results from an Australian pregnancy cohort study
    Woolhouse, Hannah
    Gartland, Deirdre
    Papadopoullos, Sandra
    Mensah, Fiona
    Hegarty, Kelsey
    Giallo, Rebecca
    Brown, Stephanie
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 251 : 71 - 77
  • [32] Findings from an online survey of family carer experience of the management of challenging behaviour in people with intellectual disabilities, with a focus on the use of psychotropic medication
    Sheehan, Rory
    Kimona, Kate
    Giles, Audrey
    Cooper, Vivien
    Hassiotis, Angela
    BRITISH JOURNAL OF LEARNING DISABILITIES, 2018, 46 (02) : 82 - 91
  • [33] Long-term outcome of a cohort of adults with autism and intellectual disability: A pilot prospective study
    Fusar-Poli, Laura
    Brondino, Natascia
    Orsi, Paolo
    Provenzani, Umberto
    De Micheli, Andrea
    di Nemi, Stefania Ucelli
    Barale, Francesco
    Politi, Pierluigi
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2017, 60 : 223 - 231
  • [34] Comparing self-report medication data from a longitudinal study on intellectual disability and national dispensing records
    Gorman, A.
    Odalovic, M.
    McCallion, P.
    Paul, A.
    Burke, E.
    MacLachlan, M.
    McCarron, M.
    Henman, M. C.
    Moran, M.
    O'Connell, J.
    Shankar, R.
    Ryan, C.
    O'Dwyer, M.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2025, 69 (01) : 103 - 111
  • [35] Risk factors for potentially inappropriate medication use in older adults: a cohort study
    de Araujo, Natacha Christina
    Silveira, Erika Aparecida
    Mota, Brenda Godoi
    Guimaraes, Rafael Alves
    Figueiredo Modesto, Ana Carolina
    Pagotto, Valeria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (05) : 1132 - 1139
  • [36] Risk factors for potentially inappropriate medication use in older adults: a cohort study
    Natacha Christina de Araújo
    Erika Aparecida Silveira
    Brenda Godoi Mota
    Rafael Alves Guimarães
    Ana Carolina Figueiredo Modesto
    Valéria Pagotto
    International Journal of Clinical Pharmacy, 2022, 44 : 1132 - 1139
  • [37] Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study
    Zaal, Rianne J.
    Ebbers, Susan
    Borms, Mirka
    de Koning, Bart
    Mombarg, Erna
    Ooms, Piet
    Vollaard, Hans
    van den Bemt, Patricia M. L. A.
    Evenhuis, Heleen M.
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2016, 55 : 132 - 142
  • [38] COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
    Naqvi, Danial
    Perera, Bhathika
    Mitchell, Sarah
    Sheehan, Rory
    Shankar, Rohit
    BJPSYCH OPEN, 2021, 8 (01):
  • [39] Screening for Dementia among Adults with Intellectual Disability: Outcomes from a Pilot Study
    Holingue, Calliope
    Wise, Elizabeth
    Caoili, Andrea
    Klein, Ann
    Kalb, Luther G.
    Beasley, Joan
    JOURNAL OF MENTAL HEALTH RESEARCH IN INTELLECTUAL DISABILITIES, 2022, 15 (01) : 20 - 36
  • [40] Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: A nationwide outpatient service study, 1997-2007
    Hsu, Shang-Wei
    Chiang, Po-Huang
    Chang, Yu-Chia
    Lin, Jin-Ding
    Tung, Ho-Jui
    Chen, Chao-Yun
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2014, 35 (02) : 364 - 372